Actinium Pharmaceuticals Inc (ATNM)
7.04
+0.08
(+1.15%)
USD |
NYAM |
Apr 24, 16:00
7.04
0.00 (0.00%)
After-Hours: 19:25
Actinium Pharmaceuticals Profit Margin (Quarterly): -11.51K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.51K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -21.05K% |
| Date | Value |
|---|---|
| June 30, 2022 | -17.26K% |
| March 31, 2022 | -545.6% |
| December 31, 2021 | -34.83K% |
| September 30, 2021 | -2.76K% |
| June 30, 2021 | -1.89K% |
| March 31, 2021 | -855.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-34.83K%
Minimum
Dec 2021
-545.6%
Maximum
Mar 2022
-11.34K%
Average
-7.13K%
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Eli Lilly and Co | 23.41% |
| Cellectar Biosciences Inc | -- |
| Bristol-Myers Squibb Co | 15.35% |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -95.08% |
| Return on Assets | -50.26% |
| Return on Invested Capital | -95.08% |
| Operating Margin (Quarterly) | -12.77K% |
| Return on Net Operating Assets | -1.12K% |